We are monitoring the impact of COVID-19 on APAC Insulin Pump Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 10552
Share on
Share on

Asia-pacific Insulin Pump Market Research Report – Segmented By Type, End User and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 10552
Pages: 120

APAC Insulin Pump Market Size (2021 to 2026)

The Asia pacific insulin pump market size is estimated to hike at a CAGR of 10.1% between 2021 to 2026 and worth USD 1,986 million by the end of 2026.

Y-O-Y growth in diabetes prevalence in Asia-Pacific and rising focus on effective diabetes management care among the population are majorly accelerating the insulin pump market growth in the APAC region. 

According to the data published by the journalofdiabetology.org, an estimated 80 million people had diabetes in southeast Asia in 2017; this figure is further expected to hit 151 million by 2045. As World Health Organization, an estimated 10% of the adult population of China has diabetes. An estimated 72.96 million adult population in India has had diabetes. According to WHO, in Bangladesh, the prevalence of diabetes is growing at a significant rate. It was 5% in the entire population between 2001 to 2005 and had increased to 9% between 2006 to 2010.

The COVID-19 pandemic has helped the APAC insulin pump market grow further as there is a spike in insulin pump sales during this period. The growing diabetes population in this region are reportedly used insulin pumps to manage their diabetes, and this has mainly happened in the developing nations of the region.

Growing incidence of lifestyle diseases, increasing APAC government initiatives to introduce new technologies, and increasing demand for upgraded medical facilities are majorly escalating the insulin pump growth in this region. Nearly 114.1 million in China are said to be suffering from diabetes (type I & type II), and of these two, type II diabetes is more regular in patients.

Technological developments are another significant factor favoring the market to grow further. For instance, “Medtronic” has maintained its position as the key market player in the Asia-Pacific due to its invention in technology advancements offering the patient in need and implementing combined agreements. The fierce competition from the local market players is anticipated to increase the growth of the Asia-Pacific insulin pump market during the forecast period.

Lack of prominence in enhancing healthcare services and restricted access to technological advancements may restrain the insulin pump market growth in the region. The deficit of alertness and strict administrative and government schemes restrict the region's market growth over the review period. The cost of the insulin pumps is high, and the pricing pressure of the consumables is hampering the market growth in APAC.

This research report on the Asia-Pacific insulin pump market has been segmented and sub-segmented into the following categories:

By Pump Type:

  • Traditional
  • Disposable

By End User:

  • Hospitals & Clinics
  • Homecare
  • Laboratories
  • Others

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, the insulin pump market in the Asia-Pacific region is expected to have a robust CAGR and is also considered a profit-producing region.

In this region, the Chinese insulin pumps market is expected to lead the APAC insulin pump market during the forecast period due to its financial growth and enormous diabetic people's existence. Acquiring the latest technologies in improved nations of the region is likely to propel the growth.

The Japanese insulin pumps market has the fastest growth rate due to swelling in discretionary expenses and easy accessibility of superior medical solutions. Robust growth rate and surge in per head expenses made towards healthcare integrated with huge patient count suffering from diabetic.

The Indian insulin pumps market is predicted to grow at a CAGR of 9.25% from 2020 to 2025. The growing patient population and increasing healthcare expenditure are majorly contributing to the growth of the Indian market.

Companies such as Animus Corporation (U.S.), Asante (U.S.), Cellnovo Ltd. (U.K.), Insulet Corporation (U.S.), Medtronics, Inc. (U.S.), Nipro Diagnostic, Inc. (Japan), Ypsomed (Switzerland), Roche (Switzerland), Sooil Development Co., Ltd. (Korea) and Tandem Diabetes Care, Inc. (U.S.) are adding significant share to the Asia-Pacific insulin pump market.

  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Type
      1. Traditional Insulin Pumps
      2. Disposable Insulin Pumps
      3. Y-o-Y Growth Analysis, By Type
      4. Market Attractiveness Analysis, By Type
      5. Market Share Analysis, By Type
    2. By End User
      1. Hospitals & Clinics
      2. Homecare
      3. Laboratories
      4. Others
      5. Y-o-Y Growth Analysis, By End User
      6. Market Attractiveness Analysis, By End User
      7. Market Share Analysis, By End User
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends       
      2. Impact Analysis        
      3. Y-o-Y Growth Analysis            
        1. By Geographical Area
        2. By Type
        3. By End User
      4. Market Attractiveness Analysis          
        1. By Geographical Area
        2. By Type
        3. By End User
      5.          Market Share Analysis   
        1. By Geographical Area
        2. By Type
        3. By End User
    2. Asia-Pacific
      1. Introduction
      2. India
      3. China
      4. Japan
      5. South Korea
      6. Australia
      7. Rest of Asia-Pacific
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Animus Corporation (U.S.)
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Asante (U.S.)
    3. Cellnovo Ltd. (U.K.)
    4. Insulet Corporation (U.S.)
    5. Medtronics, Inc. (U.S.)
    6. Nipro Diagnostic, Inc. (Japan)
    7. Ypsomed (Switzerland)
    8. Roche (Switzerland)
    9. Sooil Development Co., Ltd. (Korea)
    10. Tandem Diabetes Care, Inc. (U.S.)
  9. Competitive Landscape
    1. Merger and Acquisition Analysis
    2. Agreements, Collaborations and Joint Ventures
    3. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures  
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of pump type and end-user, along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographics, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Global Insulin Pump Market, By Pump Type, From 2021 to 2026 (USD Billion)
  2. Asia Pacific Traditional Market, By Region, From 2021 to 2026 (USD Billion)
  3. Asia Pacific Dispoasble Market, By Region, From 2021 to 2026 (USD Billion)
  4. Asia Pacific Global Insulin Pump Market, By End User, From 2021 to 2026 (USD Billion)
  5. Asia Pacific Hospitals & Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  6. Asia Pacific HomeCare Market, By Region, From 2021 to 2026 (USD Billion)
  7. Asia Pacific Laboratories Market, By Region, From 2021 to 2026 (USD Billion)
  8. Asia Pacific Others Market, By Region, From 2021 to 2026 (USD Billion)
  9. Japan Global Insulin Pump Market, By Pump Type, From 2021 to 2026 (USD Billion)
  10. Japan Global Insulin Pump Market, By End User, From 2021 to 2026 (USD Billion)
  11. China Global Insulin Pump Market, By Pump Type, From 2021 to 2026 (USD Billion)
  12. China Global Insulin Pump Market, By End User, From 2021 to 2026 (USD Billion)
  13. India Global Insulin Pump Market, By Pump Type, From 2021 to 2026 (USD Billion)
  14. India Global Insulin Pump Market, By End User, From 2021 to 2026 (USD Billion)
  15. Australia Global Insulin Pump Market, By Pump Type, From 2021 to 2026 (USD Billion)
  16. Australia Global Insulin Pump Market, By End User, From 2021 to 2026 (USD Billion)
  17. South Korea Global Insulin Pump Market, By Pump Type, From 2021 to 2026 (USD Billion)
  18. South Korea Global Insulin Pump Market, By End User, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample